Comparing XWELL (XWEL) and Its Rivals

XWELL (NASDAQ:XWELGet Rating) is one of 63 public companies in the “Personal services” industry, but how does it compare to its rivals? We will compare XWELL to similar businesses based on the strength of its analyst recommendations, valuation, earnings, risk, dividends, profitability and institutional ownership.

Insider & Institutional Ownership

13.4% of XWELL shares are owned by institutional investors. Comparatively, 50.2% of shares of all “Personal services” companies are owned by institutional investors. 2.3% of XWELL shares are owned by company insiders. Comparatively, 22.0% of shares of all “Personal services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares XWELL and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
XWELL -20.72% -19.57% -15.07%
XWELL Competitors -18.06% -53.91% -4.08%

Volatility and Risk

XWELL has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, XWELL’s rivals have a beta of 1.18, indicating that their average share price is 18% more volatile than the S&P 500.

Valuation and Earnings

This table compares XWELL and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
XWELL $73.73 million $3.35 million -2.59
XWELL Competitors $659.01 million $53.72 million 360.47

XWELL’s rivals have higher revenue and earnings than XWELL. XWELL is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and price targets for XWELL and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
XWELL 0 0 1 0 3.00
XWELL Competitors 193 850 1447 63 2.54

XWELL presently has a consensus price target of $1.50, indicating a potential upside of 240.91%. As a group, “Personal services” companies have a potential upside of 30.91%. Given XWELL’s stronger consensus rating and higher possible upside, analysts plainly believe XWELL is more favorable than its rivals.

Summary

XWELL rivals beat XWELL on 8 of the 13 factors compared.

XWELL Company Profile

(Get Rating)

XWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.

Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.